Seeking AlphaSeeking Alpha

Fresenius SE cuts Fresenius Medical Care stake to 20%

Займёт меньше минуты

Fresenius Medical Care FMS shares spiked in premarket trading on Thursday after its parent, Fresenius SE FSNUF FSNUY, announced that it reduced its stake in the dialysis provider to ~20% from ~25%.

In a statement, the German healthcare company said it sold 13.4M shares in Fresenius Medical Care FMCQF FSNUF for €39.00 each, generating roughly €524M in gross proceeds and reducing its investment by approximately 5%.

The company added that it intends to utilize the net proceeds in its growth platforms consistent with capital allocation targets established as part of its #FutureFresenius initiative.

The transaction will lead to a book gain in the low- to mid-double-digit million euro range, which will be reflected in the Fresenius Group’s Q4 2026 results.

Since its deconsolidation of Fresenius Medical Care in 2023, the company has reduced the financial investment in its subsidiary from ~32% to ~20%, generating roughly €2.3B in total gross proceeds.

Отказ от ответственности